{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:11:07Z","timestamp":1786997467368,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.thromres.2010.01.039","type":"journal-article","created":{"date-parts":[[2010,2,25]],"date-time":"2010-02-25T05:46:25Z","timestamp":1267076785000},"page":"S57-S59","source":"Crossref","is-referenced-by-count":15,"special_numbering":"S1","title":["Interdependent biological systems, multi-functional molecules: The evolving role of tissue factor pathway inhibitor beyond anti-coagulation"],"prefix":"10.1016","volume":"125","author":[{"given":"Eric W.","family":"Holroyd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Simari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.thromres.2010.01.039_bib1","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1046\/j.1538-7836.2003.00334.x","article-title":"450 million years of hemostasis","volume":"1","author":"Davidson","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2010.01.039_bib2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood.V71.2.335.335","article-title":"The lipoprotein-associated coagulation inhibitor that inhibits factor Xa: insight into its possible mechanism of action","volume":"71","author":"Broze","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2010.01.039_bib3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/338518a0","article-title":"G.J. Broze J. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor","volume":"338","author":"Girard","year":"1989","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.thromres.2010.01.039_bib4","first-page":"407","article-title":"Infection\/inflammation and hemostasis","volume":"2","author":"Vincent","year":"2003","journal-title":"Curr Hematol Rep"},{"issue":"1","key":"10.1016\/j.thromres.2010.01.039_bib5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bcmd.2004.09.001","article-title":"Blood coagulation factors as inflammatory mediators","volume":"34","author":"Schoenmakers","year":"2005","journal-title":"Blood Cells Mol Dis"},{"issue":"5","key":"10.1016\/j.thromres.2010.01.039_bib6","first-page":"1087","article-title":"Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis","volume":"134","author":"Drake","year":"1989","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.thromres.2010.01.039_bib7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2141.1975.tb00547.x","article-title":"The endotoxin-induced coagulant activity of human monocytes","volume":"30","author":"Rivers","year":"1975","journal-title":"Br J Haematol"},{"issue":"5633","key":"10.1016\/j.thromres.2010.01.039_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/270173a0","article-title":"Further link between complement activation and blood coagulation","volume":"270","author":"Prydz","year":"1977","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.thromres.2010.01.039_bib9","first-page":"1353","article-title":"The pleiotropic effects of tissue factor: a possible role for factor VIIa-induced intracellular signalling?","volume":"86","author":"Versteeg","year":"2001","journal-title":"Thromb Haemost"},{"issue":"7","key":"10.1016\/j.thromres.2010.01.039_bib10","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1046\/j.1538-7836.2003.00300.x","article-title":"Specificity of coagulation factor signaling","volume":"1","author":"Ruf","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.thromres.2010.01.039_bib11","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1182\/blood-2003-09-3051","article-title":"Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia","volume":"103","author":"Pawlinski","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2010.01.039_bib12","first-page":"127","article-title":"Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody","volume":"33","author":"Taylor","year":"1991","journal-title":"Circ Shock"},{"issue":"1","key":"10.1016\/j.thromres.2010.01.039_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00003246-200101000-00003","article-title":"The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsis","volume":"29","author":"Opal","year":"2001","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.thromres.2010.01.039_bib14","first-page":"126","article-title":"Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram-negative model of septic shock","volume":"44","author":"Carr","year":"1994","journal-title":"Circ Shock"},{"issue":"2","key":"10.1016\/j.thromres.2010.01.039_bib15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.290.2.238","article-title":"Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial","volume":"290","author":"Abraham","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2010.01.039_bib16","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1182\/blood.V90.5.1883","article-title":"A novel degradation pathway of tissue factor pathway inhibitor: incorporation into fibrin clot and degradation by thrombin","volume":"90","author":"Ohkura","year":"1997","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.thromres.2010.01.039_bib17","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1086\/599097","article-title":"Fragmented tissue factor pathway inhibitor (TFPI) and TFPI C-terminal peptides eliminate serum-resistant Escherichia coli from blood cultures","volume":"199","author":"Schirm","year":"2009","journal-title":"J Infect Dis"},{"issue":"2\u20133","key":"10.1016\/j.thromres.2010.01.039_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1385\/IR:21:2-3:289","article-title":"Diverse functions of protease receptor tissue factor in inflammation and metastasis","volume":"21","author":"Ruf","year":"2000","journal-title":"Immunol Res"},{"key":"10.1016\/j.thromres.2010.01.039_bib19","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1172\/JCI930","article-title":"Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis","volume":"101","author":"Mueller","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.thromres.2010.01.039_bib20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nm0296-209","article-title":"In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease","volume":"2","author":"Contrino","year":"1996","journal-title":"Nature Med"},{"issue":"6","key":"10.1016\/j.thromres.2010.01.039_bib21","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/ATVBAHA.107.142539","article-title":"Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis","volume":"27","author":"Uusitalo-Jarvinen","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.thromres.2010.01.039_bib22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1182\/blood-2007-07-101048","article-title":"Inhibition of tissue factor signaling suppresses tumor growth","volume":"111","author":"Versteeg","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.thromres.2010.01.039_bib23","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nm1037","article-title":"Regulation of angiogenesis by tissue factor cytoplasmic domain signaling","volume":"10","author":"Belting","year":"2004","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.thromres.2010.01.039_bib24","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1182\/blood-2004-09-3422","article-title":"Regulation of tissue factor-induced signaling by endogenous and recombinant tissue factor pathway inhibitor 1","volume":"105","author":"Ahamed","year":"2005","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.thromres.2010.01.039_bib25","first-page":"2997","article-title":"Tissue factor\/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism","volume":"63","author":"Hembrough","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.thromres.2010.01.039_bib26","doi-asserted-by":"crossref","first-page":"12241","DOI":"10.1074\/jbc.M010395200","article-title":"Tissue factor pathway inhibitor inhibits endothelial cell proliferation via association with the very low density lipoprotein receptor","volume":"276","author":"Hembrough","year":"2001","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.thromres.2010.01.039_bib27","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1182\/blood-2003-07-2234","article-title":"Identification and characterization of a very low density lipoprotein receptor-binding peptide from tissue factor pathway inhibitor that has antitumor and antiangiogenic activity","volume":"103","author":"Hembrough","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2010.01.039_bib28","first-page":"959","article-title":"Structure and biology of tissue factor pathway inhibitor","volume":"86","author":"Bajaj","year":"2001","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.thromres.2010.01.039_bib29","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1160\/TH07-10-0623","article-title":"Tissue factor pathway inhibitor (TFPI) interferes with endothelial cell migration by inhibition of both the Erk pathway and focal adhesion proteins","volume":"99","author":"Provencal","year":"2008","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.thromres.2010.01.039_bib30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1383\/medc.30.4.54.28290","article-title":"The Endothelium and the Pathogenesis of Atherosclerosis","volume":"30","author":"Channon","year":"2002","journal-title":"Medicine"},{"issue":"14","key":"10.1016\/j.thromres.2010.01.039_bib31","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/01.CIR.0000143233.87854.23","article-title":"Plaque neovascularization is increased in ruptured therosclerotic lesions of human aorta: implications for plaque vulnerability","volume":"110","author":"Moreno","year":"2004","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.thromres.2010.01.039_bib32","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1016\/S0021-9258(18)68737-X","article-title":"Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains","volume":"263","author":"Wun","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2010.01.039_bib33","doi-asserted-by":"crossref","first-page":"18832","DOI":"10.1016\/S0021-9258(18)51542-8","article-title":"Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma","volume":"264","author":"Novotny","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2010.01.039_bib34","doi-asserted-by":"crossref","first-page":"6664","DOI":"10.1073\/pnas.91.14.6664","article-title":"The low density lipoprotein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor","volume":"91","author":"Warshawsky","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"42","key":"10.1016\/j.thromres.2010.01.039_bib35","doi-asserted-by":"crossref","first-page":"24800","DOI":"10.1074\/jbc.270.42.24800","article-title":"GJ Broze J, Schwartz A. Two receptor systems are involved in the plasma clearance of tissue factor pathway inhibitor in vivo","volume":"270","author":"Narita","year":"1995","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.thromres.2010.01.039_bib36","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-0037-1612947","article-title":"Oxidized low-density lipoprotein associates strongly with carboxy-terminal domain of tissue factor pathway inhibitor and reduces the catalytic activity of the protein","volume":"87","author":"Horie","year":"2002","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.thromres.2010.01.039_bib37","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1089\/1523086041361686","article-title":"Oxidized phospholipids in oxidized low-density lipoprotein reduce the activity of tissue factor pathway inhibitor through association with its carboxy-terminal region","volume":"6","author":"Ohkura","year":"2004","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"10.1016\/j.thromres.2010.01.039_bib38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/hh1301.092508","article-title":"Role for tissue factor pathway in murine model of vascular remodeling","volume":"89","author":"Singh","year":"2001","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.thromres.2010.01.039_bib39","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1160\/TH04-01-0006","article-title":"The effect of vascular smooth muscle cell-targeted expression of tissue factor pathway inhibitor in a murine model of arterial thrombosis","volume":"92","author":"Pan","year":"2004","journal-title":"Thromb Haemost"},{"issue":"25","key":"10.1016\/j.thromres.2010.01.039_bib40","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1161\/hc2501.092492","article-title":"Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice","volume":"103","author":"Westrick","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2010.01.039_bib41","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1055\/s-0037-1613582","article-title":"Tissue factor pathway inhibitor deficiency enhances neointimal proliferation and formation in a murine model of vascular remodeling","volume":"89","author":"Singh","year":"2003","journal-title":"Thromb Haemost"},{"issue":"7","key":"10.1016\/j.thromres.2010.01.039_bib42","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/CIRCRESAHA.109.195016","article-title":"Vascular-directed tissue factor pathway inhibitor overexpression regulates plasma cholesterol and reduces atherosclerotic plaque development","volume":"105","author":"Pan","year":"2009","journal-title":"Circ Res"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384810000927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384810000927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T23:16:34Z","timestamp":1635030994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384810000927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":42,"alternative-id":["S0049384810000927"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2010.01.039","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}